STOK Stoke Therapeutics, Inc.

8d ago, source: Seeking Alpha

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its ...

Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Lags Revenue Estimates

1mon ago, source: Nasdaq

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.60 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.65 per share a year ago.

Stoke Therapeutics Inc (STOK) Beta Value: Understanding the Market Risk

10d ago, source: newsheater

Nash Huw M., the COO & CBO of Stoke Therapeutics Inc, sale 61,329 shares at $13.23 during a trade that took place back on Apr 01 ’24, which means that Nash Huw M. is holding 0 shares at $811,212 based ...

Stoke Therapeutics Stock (NASDAQ:STOK), Analyst Ratings, Price Targets, Predictions

24d ago, source: Benzinga.com

There is no last downgrade for Stoke Therapeutics.

Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering

1mon ago, source: Nasdaq

BEDFORD, Mass.--(BUSINESS WIRE)-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein ...

Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer

17d ago, source: Stockhouse

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today ...

Assessing Stoke Therapeutics: Insights From 6 Financial Analysts

1mon ago, source: Business Insider

Unveiling the Story Behind Stoke Therapeutics Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines ...

Stoke Therapeutics, Inc. (STOK)

2mon ago, source: Yahoo Finance

Get prepared with the key expectations. BEDFORD, Mass., April 17, 2024--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe ...

Stoke Therapeutics Inc STOK

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...